United lands ‘clearcut win’ as Liquidia agrees to $380M settlement in Tyvaso patent infringement saga
With a yearslong patent dispute between the two drugmakers finally put to bed—complete with a hefty settlement payout—United Therapeutics has clinched what one analyst calls a “clearcut win” over l | With a yearslong patent dispute between the two drugmakers finally put to bed—complete with a hefty settlement payout—United Therapeutics has clinched what one analyst calls a “clearcut win” over lung disease rival Liquidia Technologies.